AGXT and myocardial infarction: Experimental myocardial infarction (MI) performed on C57B/L6 mice induced altered sphingolipid metabolism, with increased expression of the first and rate-limiting enzyme in the de novo pathway, serine palmitoyl transferase (SPT), and consequently increased ceramide levels [12].